IM Cannabis (IMCC) Change in Account Payables (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Change in Account Payables of -$1.9 million in Q1 2026, down 147.83% quarter-over-quarter from $4.0 million in Q4 2025, and down 152.61% on a YoY basis from $3.7 million in Q1 2025.
IM Cannabis (IMCC) Change in Account Payables (2020 - 2026) Analysis & Trends
IM Cannabis' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 152.61% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$4.5 million (down 150.5% YoY), while the FY2025 annual figure was $1.2 million, down 78.25% from the prior year.
- Change in Account Payables was -$1.9 million for Q1 2026 at IM Cannabis, down from $4.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.9 million in Q2 2024 to a low of -$4.5 million in Q1 2023.
- Historically, Change in Account Payables has averaged $533640.1 across 5 years, with a median of $702018.7 in 2023.
- The sharpest annual moves came in 2022 and 2023: Change in Account Payables jumped 1010.21% in 2022, then plunged 337.33% in 2023.
- A 5-year view of Change in Account Payables shows it stood at $2.4 million in 2022, then sank by 144.17% to -$1.1 million in 2023, then tumbled by 85.34% to -$2.0 million in 2024, then jumped by 305.23% to $4.0 million in 2025, then plunged by 147.83% to -$1.9 million in 2026.
- The last three Change in Account Payables figures came in at -$1.9 million (Q1 2026), $4.0 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn | -1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 492,021.06 |
| Mar 31, 2024 | 492,021.06 |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |